A 2025 study published by the National Institutes of Health described BPC-157 as having antioxidant, anti-inflammatory and wound-healing effects in preclinical models in animals, but it emphasized that comprehensive human clinical studies were lacking
Serious side effects include muscle weakness, extreme thirst, confusion, shortness of breath, headache, exhaustion, reddening of the skin, and a fast or irregular heartbeat
If you drink while on a BPC-157 protocol, the combined sleep effects may compound
Increases in heart rate were observed, consistent with semaglutide therapy
Some people may experience headaches or digestive discomfort, but these side effects usually resolve quickly